$7.1 Billion Medical Refrigerators Market and Industry Insights, 2024-2030, Featuring Strategic Analysis of 42 Major Players, Including Godrej, Haier Biomedical, Thermo Fisher Scientific
Thermo Fisher Scientific's (NYSE:TMO) 14% CAGR Outpaced the Company's Earnings Growth Over the Same Five-year Period
CytoReason Secures $80M From OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific to Scale Its AI Disease Models and Establish US Hub in Cambridge, Massachusetts
New funding will expand CytoReason's disease models and proprietary data, enabling R&D leaders at partner companies to make strategic decisions with greater speed and precision.TEL AVIV, Israel--(
NIH Outlays Rise by 5% in June, Says Baird
AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates
The Zacks Analyst Blog DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific
Jefferies Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Maintains Target Price $650
Jefferies analyst Tycho Peterson maintains $Thermo Fisher Scientific(TMO.US)$ with a buy rating, and maintains the target price at $650.According to TipRanks data, the analyst has a success rate of 56
Scaffold Technology - Global Market Size, Industry Dynamics, Opportunity Analysis, Forecast, and Competitive Landscape (2024-2032) Featuring Thermo Fisher Scientific, Agilent Technologies, and Tecan Trading
Buy 5 Medical Devices Stocks to Enhance Your Portfolio in 2H
The Medical Instruments industry is highly fragmented, with participants engaged in research and development (R&D) in therapeutic areas.
Why Is Thermo Fisher Scientific Inc. (TMO) the Best Industrial Stock to Buy According to Hedge Funds?
These Are the Stocks With the Highest Increase in Short Interest Within Life Sciences and Diagnostics - Baird
Looking At Thermo Fisher Scientific's Recent Unusual Options Activity
Financial giants have made a conspicuous bearish move on Thermo Fisher Scientific. Our analysis of options history for Thermo Fisher Scientific (NYSE:TMO) revealed 9 unusual trades.Delving into the
Thermo Fisher (TMO) Inks New Partnership for MyeloMATCH Trial
Thermo Fisher Scientific To Go Ex-Dividend On September 13th, 2024 With 0.39 USD Dividend Per Share
July 11th (Eastern Time) - $Thermo Fisher Scientific(TMO.US)$ is trading ex-dividend on September 13th, 2024.Shareholders of record on September 13th, 2024 will receive 0.39 USD dividend per share
Express News | Thermo Fisher Scientific Inc - Authorized a Quarterly Cash Dividend of $0.39 per Common Share
Press Release: Thermo Fisher Scientific Declares Quarterly Dividend
Thermo Fisher Scientific Declares Quarterly Dividend WALTHAM, Mass.--(BUSINESS WIRE)--July 11, 2024-- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced
TMO or IDXX: Which Is the Better Value Stock Right Now?
Thermo Fisher Scientific Inc.'s (NYSE:TMO) P/E Is On The Mark
With a price-to-earnings (or "P/E") ratio of 34x Thermo Fisher Scientific Inc. (NYSE:TMO) may be sending very bearish signals at the moment, given that almost half of all companies in the United
Thermo Fisher Scientific's MyeloMATCH Precision Medicine Clinical Trial Leverages Next-Day Genomic Testing To Quickly Match Patients With Appropriate Trials Across North America
myeloMATCH Precision Medicine Clinical Trial Leverages Next-Day Genomic Testing to Quickly Match Patients with Appropriate Trials Across North AmericaTo help accelerate research into new treatments
Express News | Thermo Fisher Scientific Inc - Partnering With National Cancer Institute on Myelomatch Precision Medicine Umbrella Trial